NWAG
PFE icon

Net Worth Advisory Group’s Pfizer PFE Stock Holding History

Net Worth Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$717K Sell
29,766
-3,122
-9% -$81.7K 0.18% 134
2026
Q1 		$923K Sell
32,888
-455
-1% -$12.1K 0.19% 104
2025
Q4 		$830K Buy
+33,343
New +$841K 0.17% 120

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Net Worth Advisory Group's PFE Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Pfizer (PFE) stake by 9.5% in Q2 2026, selling an estimated $81.7K and leaving 29,766 shares worth $717K. The position accounts for 0.18% of the portfolio, ranked #134.

Net Worth Advisory Group first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $923K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Net Worth Advisory Group held 29,766 shares of Pfizer worth $717K as of Q2 2026.
  • Net Worth Advisory Group sold 3,122 Pfizer shares in Q2 2026, an estimated $81.7K.
  • Pfizer made up 0.18% of Net Worth Advisory Group's portfolio in Q2 2026, its #134 holding.
  • Net Worth Advisory Group first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Net Worth Advisory Group's Pfizer position peaked at $923K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.